Live Breaking News & Updates on Ongoing phase

Stay updated with breaking news from Ongoing phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Philadelphia , Pennsylvania , United-states , American , David-alexandrec-gros , Eledon-pharmaceuticals-inc , American-transplant-congress , Ongoing-phase , Antibody-tegoprubart , Kidney-transplant , Chief-executive-officer

Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting

Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , Watertown , Massachusetts , Boston , American , Justine-koenigsberg , Jared-gollob , American-society-of-clinical-oncology , Nasdaq , Exchange-commission , University-of-texas-md-anderson-cancer-center

X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia

X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Austria , Massachusetts , United-states , Boston , Vienna , Wien , Pharmaceuticals-to-host-virtual-investor-event-on , Head-of-corporate-patient-affairs , Company-contact , Pharmaceuticals-nasdaq , Exchange-commission

Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024

Presentations to Include New Antiviral Efficacy Results, Including SVR12 Data, from Lead-In Cohort of Ongoing Phase 2 HCV Trial Data Also Highlight the High Prevalence of Pre-Existing NS5A. ....

Boston , Massachusetts , United-states , Italy , Milan , Lombardia , Jean-pierre-sommadossi , Jonae-barnes , Qi-huang , Alina-jucov , Atea-pharmaceuticals-inc , Globenewswire-inc